Código QR (código de barras bidimensional)

Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world study

Abstract Background The combination of transcatheter arterial chemoembolization (TACE) plus sorafenib prolonged progression-free survival (PFS) and overall survival (OS) than sorafenib or TACE monotherapy for patients with hepatocellular carcinoma (HCC). This study assessed the efficacy and safety o...

ver descrição completa

Na minha lista:
Principais autores: Jian-Xu Li, Wen-Xiang Deng, Shi-Ting Huang, Xiao-Feng Lin, Mei-Ying Long, Jie Zhang, Ting-Shi Su, Li-Qing Li, Ya-Dan Pang, Chun-Feng Liang, Hong-Mei Zhou, Hai-Yan Lu, Shi-Xiong Liang, Bang-De Xiang
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2022-06-01
coleção:Radiation Oncology
Assuntos:
Hepatocellular carcinoma
Anti-PD1
Radiotherapy
Overall survival
Transcatheter arterial chemoembolization
Sorafenib
Acesso em linha:https://doi.org/10.1186/s13014-022-02075-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados